Stocks

Capricor Therapeutics CAPR

Health care sectorNasdaq

What to see in Capricor Therapeutics now

Is Wall Street adding or cutting?−7

170 13F filers hold it · −7 against the quarter before · shares held +16.0%

Holdings of 06/30
Who bought more than 5%?5.1%

Millennium Management holds 5.1% · +0.2pp on the report before

Filed 09/14

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
San Diego, California
Fiscal year end
12/31
Next earnings
11/12, estimated
  • 170 13F filers hold it · −7 against the quarter before · shares held +16.0%Holdings of 06/30
  • Millennium Management holds 5.1% · +0.2pp on the report beforeFiled 09/14

Funds

13F filers: 170 · −7 since the quarter before · 06/30 holdings

Famous funds that held Capricor Therapeutics in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsCapricor Therapeutics CAPR · 06/30 holdings$763.3KNo quarter before
All tracked funds

5% stakes

Holder
Millennium Management09/145.1%2,943,086 sh+0.2pp
Millennium Management08/194.9%2,857,387 shFirst report
State Street08/075.9%3,397,241 shFirst report
Ra Capital Management08/035.2%3,014,183 shFirst report
Suvretta Capital Management02/266.6%3,417,891 shFirst report
Tang Capital Management01/266.6%3,399,900 shFirst report
Vanguard Group25/10/304.82%2,206,719 sh−0.2pp
Vanguard Group25/07/295.04%2,305,078 sh+0.1pp
Vanguard Group25/04/304.95%2,263,991 sh−0.1pp
Vanguard Group25/01/305%2,276,784 shFirst report
All 5% stake reports on Capricor Therapeutics

26-week trading